Trial Profile
PHASE 1 TRIAL OF ONCOLYTIC ADENOVIRUS-MEDIATED CYTOTOXIC AND IL-12 GENE THERAPY IN COMBINATION WITH CHEMOTHERAPY FOR THE TREATMENT OF METASTATIC PANCREATIC CANCER
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Mar 2022
Price :
$35
*
At a glance
- Drugs Ad5 yCD/mutTK(SR39)rep ADP (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions
- 15 Feb 2022 Status changed from recruiting to completed.
- 15 Sep 2017 New trial record